在调节AR活动中对正和正联体的研究:一个分子动力学研究
Xiaotian Kong1, Yushan Zou2, Peng Cao1
1College of Chemistry and Life Science, Beijing International Science and Technology Cooperation Base for Intelligent Physiological Measurement and Clinical Transformation, Beijing University of Technology, Beijing 100124, China.
Journal of chemical information and modeling
|October 13, 2025
概括
与标准治疗相结合的Allosteric BF3抗剂可以通过破坏雄激素受体 (AR) 功能来克服前列腺癌中的抗性. 这一策略提高了疗效,并向了这种疾病的抵抗割的形式.
科学领域:
- 分子生物学和计算化学.
- 前列腺癌治疗方法 前列腺癌治疗方法
- 雄激素受体信号传递方式
背景情况:
- 雄激素受体 (AR) 是前列腺癌治疗的关键点.
- 对当前AR抗剂 (例如,胺胺) 的耐药性源于连接体结合口袋 (LBP) 中的突变.
- 向BF3部位的阿洛斯特抗剂显示出有前途,但有效性有限.
研究的目的:
- 调查BF3位点抗剂与LBP连接体对AR活性的合作作用.
- 了解BF3抗剂克服抗性的分子机制.
- 为开发前列腺癌新型组合疗法提供基础.
主要方法:
- 综合计算建模:高斯加速分子动力学 (GaMD).
- 自由能量的计算:MM/GBSA.
- 路径分析:用于信号通信的弹性网络模型 (ENM).
主要成果:
- BF3抗剂与LBP抗剂协同作用,破坏AR的H12螺旋体的稳定性,打开联合激活剂结合部位 (AF2).
- BF3对抗剂与特定的残留物相互作用,以全学调节AF2形状.
- 确定了参与AR抑制的关键信号通路 (BF3→AF2和LBP→AF2).
结论:
- 的BF3抗剂可以增强LBP配体的疗效,克服抵抗机制.
- 用BF3和LBP抗剂进行组合治疗,为割抵抗性前列腺癌提供了一个有前途的策略.
- 机械洞察力支持开发新的AR向治疗方法.
相关概念视频
Cooperative Allosteric Transitions
8.6K
Cooperative allosteric transitions can occur in multimeric proteins, where each subunit of the protein has its own ligand-binding site. When a ligand binds to any of these subunits, it triggers a conformational change that affects the binding sites in the other subunits; this can change the affinity of the other sites for their respective ligands. The ability of the protein to change the shape of its binding site is attributed to the presence of a mix of flexible and stable segments in the...
8.6K
Cooperative Allosteric Transitions
2.6K
2.6K
Cooperative Allosteric Transitions
3.0K
3.0K
Allosteric Regulation
62.9K
Allosteric regulation of enzymes occurs when the binding of an effector molecule to a site that is different from the active site causes a change in the enzymatic activity. This alternate site is called an allosteric site, and an enzyme can contain more than one of these sites. Allosteric regulation can either be positive or negative, resulting in an increase or decrease in enzyme activity. Most enzymes that display allosteric regulation are metabolic enzymes involved in the degradation or...
62.9K
Ligand Binding and Linkage
5.5K
Allosteric proteins have more than one ligand binding site; the binding of a ligand to any of these sites influences the binding of ligands to the other sites. When a protein is allosteric, its binding sites are called coupled or linked. In the case of enzymes, the site that binds to the substrate is known as the active site and the other site is known as the regulatory site. When a ligand binds to the regulatory site, this leads to conformational changes in the protein that can influence...
5.5K
Ligand Binding and Linkage
4.0K
4.0K


